Curative therapy of a hepatitis C infection due to an infected heart donor:
5-year outcomes after heart transplantation.
Jawad K, Feder S, Barten M, Garbade J.
Eur J Cardiothorac Surg. 2018
Mar 3.
Abstract
Understanding hepatitis C intervention success: Qualitative
findings from the HepCATT study.
Harris M,
Bonnington O, Harrison G, et al
J Viral Hepat.
2018 Jan 25.
Abstract
Assessing Hepatitis C Spontaneous Clearance and Understanding Associated
Factors: A Systematic Review and Meta-Analysis.
Aisyah DN, Shallcross L, Hully AJ,
et al
J Viral Hepat.
2018 Jan 18.
Abstract
Retreatment
of patients with treatment
failure of direct-acting
antivirals: Focus on
hepatitis C virus
genotype 1b.
Kanda T, Nirei K, Matsumoto
N, Higuchi T,
et al
World J Gastroenterol.
2017 Dec 14;23(46):8120-8127
Abstract
FULL-TEXT ARTICLE
Rapid and large-scale implementation of HCV treatment advances in France,
2007-2015
Brouard C, Boussac-Zarebska M, Silvain C,
et al
BMC Infect Dis. 2017 Dec
20;17(1):784
Paper
Management of hepatitis C in decentralised versus centralised
drug substitution programmes and minimally invasive point-of-care tests to
close gaps in the HCV cascade.
Bregenzer A, Conen A, Knuchel J,
Swiss
Med Wkly. 2017 Nov 29
Abstract
Complication Rates After Total Hip and Knee Arthroplasty in Patients With
Hepatitis C Compared With Matched Control Patients.
Cancienne JM, Kandahari AM,
Casp A
J Am Acad Orthop Surg.
2017 Dec;25(12):e275-e281
Abstract
Hepatitis C Virus: Patients’ Risk
Factors and Knowledge in an Urban Clinic Providing Wound Care.
Pieper B, Sickon K.
Wounds. 2017 Nov 20.
Abstract
Novel treatments for chronic hepatitis C: closing the
remaining gaps.
Alkhouri N, Lawitz E,
Poordad F.
Curr Opin Pharmacol. 2017
Nov 6;37:107
Cost-effectiveness of Access Expansion to Treatment of Hepatitis C Virus
Infection Through Primary Care Providers.
Rattay T, Dumont P, Heinzow HS, Hutton DW.
Gastroenterology.
2017 Oct 23
Abstract
Should we treat acute hepatitis C? A decision and
cost-effectiveness analysis.
Bethea E, Chen Q, Hur C, et al
Hepatology.
2017 Oct 23.
Abstract
Implementation of a multidisciplinary, team-based model to treat
chronic hepatitis C in the primary care setting: Lessons learned.
Sokol R, Early J, Barner A,
Gottfried S,
Healthc (Amst).
2017 Oct 18.
Abstract
Prospective longitudinal substance use patterns in patients preparing for
hepatitis C treatment.
North CS, Pollio DE, Sims OT, et al
J Dual Diagn.
2017 Oct 16:0
Abstract
Optimal cure rate by personalized HCV regimens in real-life: a proof-of-concept
study.
Cento V, Aragri M, Teti E,
et al
J Antimicrob Chemother. 2017 Sep
18.
Abstract
Treatment of hepatitis C virus infection with direct-acting
antiviral drugs is safe and effective in patients with hemoglobinopathies.
Origa R, Ponti ML, Filosa A,
et al
Am J Hematol. 2017 Sep
20.
Abstract
Can we go for a shorter treatment course in chronic hepatitis C?
More inspiring cases.
Zampino R, Vitrone M, Parrella A,
et al
J Chemother.
2017 Sep 19:1-2.
Abstract
When and how can nephrologists treat hepatitis C virus infection in dialysis
patients?
Davis MI, Chute DF, Chung RT, Sise ME.
Semin Dial. 2017 Sep
18.
Abstract
Immunogenetic studies of the hepatitis C virus infection in
an era of pan-genotype antiviral therapies – Effective treatment is coming.
Ellwanger JH, de Lima
Kaminski V,
et
al
Infect Genet Evol.
2017 Aug 12.
Abstract
After successful hepatitis C virus antiviral therapy: It
looks that normal alanine aminotransferase level is not the normal.
El Kassas M, Alboraie M, Mostafa A,
J Clin Lab Anal.
2017 Jul 28.
Abstract
Application of Exposure-Response Analyses to Establish the Pharmacodynamic
Similarity of a Once-Daily Regimen to an Approved Twice-Daily Dosing Regimen
for the Treatment of HCV Infection.
Polepally AR, Wang H,
Marroum PJ,
AAPS J.
2017 Jul 6.
Abstract
Modeling HCV cure after an ultra-short duration of therapy with
direct acting agents.
Goyal A,
Lurie Y, Meissner EG,
Antiviral Res.
2017 Jun 30;144:281-285.
Abstract
Resistance to hepatitis C virus. Implications and therapeutic options.
Llerena S, Cabezas J, Iruzubieta P, Crespo J.
Gastroenterol Hepatol. 2017 Jun 21.
Abstract
Treatment of hepatitis C with new fixed dose combinations.
Soriano V.
Expert Opin Pharmacother.
2017 Jun 23
Abstract
No one size fits all – shortening duration of therapy with direct acting
antivirals for Hepatitis C genotype 1 infection.
El Sherif O, Afhdal N, Curry
M.
J Viral
Hepat. 2017 Jun 5.
Abstract
Primary Care and Hepatology Provider-Perceived Barriers to and Facilitators
of Hepatitis C Treatment Candidacy and Adherence.
Rogal SS, McCarthy R, Reid
A, et al
Dig Dis Sci. 2017 May 18.
Abstract
FULL-TEXT ARTICLE
Long-Term Follow-Up of
Resistance-Associated Substitutions in Hepatitis C Virus in Patients in
Which Direct Acting Antiviral-Based Therapy Failed.
Yoshida K, Hai H, Tamori A, Teranishi Y. et al
Int J Mol Sci.
2017 May 3;18(5).
Paper
FULL-TEXT ARTICLE
Hepatitis C
virus management: potential impact of nanotechnology.
Elberry MH, Darwish NHE, Mousa SA.
Virol
J. 2017 May 2;14(1):88.
Paper
Treating
Hepatitis C in Patients with Renal Failure.
Lens S, Rodriguez-Tajes S, Llovet LP, et al
Dig Dis.
2017;35(4):339-346.
Abstract
Hepatitis C Virus-Genotype 3: Update on Current and Emergent Therapeutic
Interventions.
Johnson
SW, Thompson DK, Raccor B.
Curr
Infect Dis Rep. 2017
Jun;19(6):22.
Abstract
Treatment of chronic hepatitis C with direct-acting antivirals in patients
with β-thalassaemia major and advanced liver disease.
Sinakos E, Kountouras D, Koskinas J, et al
Br J
Haematol. 2017 Apr 25.
.
Abstract
Hepatitis C infection: Updates on treatment guidelines.
Pozza R, Hill C, Hefner AM, et
al
Nurse Pract. 2017 Apr
4.
Abstract
The Role of e-Health in Optimizing Task-Shifting
in the Delivery of Antiviral Therapy for Chronic Hepatitis C.
Yoo ER, Perumpail RB, Cholankeril G, et al
Telemed J E Health. 2017 Apr 4.
Abstract
Closing the Gap: The Challenges of Treating
Hepatitis C Virus Genotype 3 Infection.
Martin MT, Deming P.
Pharmacotherapy. 2017 Apr
4.
Abstract
Humanisation of a claudin-1-specific monoclonal
antibody for clinical prevention and cure of HCV infection without escape.
Colpitts CC, Tawar RG, Mailly L, et al
Gut. 2017 Mar 30.
Abstract
FULL-TEXT
ARTICLE
High Serum Lipopolysaccharide-Binding Protein Level in Chronic Hepatitis C
Viral Infection Is Reduced by Anti-Viral Treatments.
Nien HC, Hsu SJ, Su TH, et al
PLoS One. 2017 Jan 20;12(1):e0170028.
Paper
Hepatitis C: efficacy and safety in real life.
Flisiak R, Pogorzelska J, Flisiak-Jackiewicz M.
Liver Int. 2017 Jan;37
Suppl 1:26-32.
.
Abstract
Development and Preliminary Evaluation of an Integrated
Cognitive-Behavior Treatment for Chronic Pain and Substance Use Disorder in
Patients with the Hepatitis C Virus.
Morasco BJ, Greaves DW,
Lovejoy TI, et al
Pain Med.
2016 Dec;17(12):2280-2290..
Abstract
Management
of chronic hepatitis C in 2017.
v on K�ckritz L, Dufour JF.
Hamostaseologie.
2016 Nov 29.
Abstract
Mortality, Hospitalization, and Quality of Life among Patients with Hepatitis C
Infection on Hemodialysis.
Goodkin DA, Bieber B, Jadoul M,
et
al
Clin J Am Soc Nephrol.
2016 Dec 1
Abstract
A molecular transmission network of recent hepatitis C infection in people with
and without HIV: Implications for targeted treatment strategies.
Bartlett SR, Wertheim JO, Bull RA, et al
J Viral Hepat.
2016 Nov 24.
Abstract
Clinical importance of pharmacogenetics in the treatment of hepatitis C
virus infection.
Kamal AM, MitruŢ P, Kamal
KC,
et al
Rom J Morphol Embryol.
2016;57(2 Suppl):675-680.
Abstract
Value of Treating All Stages of Chronic Hepatitis C: A
Comprehensive Review of Clinical and Economic Evidence.
Nu�o Solin�s R, Arratibel
Ugarte P, et al
Infect Dis Ther.
2016 Oct 25. Review.
Abstract
FULL-TEXT ARTICLE
A practical overview of the treatment of chronic hepatitis C virus infection
Khoo A, Tse E.
Aust Fam Physician. 2016 Oct;45(10):718-720.
PaperValue of Sustained Virologic Response in Patients with Hepatitis C as a Function of Time to Progression of End-Stage Liver Disease.
Ward T, Gordon J, Jones B,
Clin Drug Investig. 2016 Sep 1.
Abstract
FULL-TEXT ARTICLE
Frequencies of Circulating MAIT Cells Are Diminished in Chronic HCV, HIV and
HCV/HIV Co-Infection and Do Not Recover during Therapy.
Spaan M, Hullegie SJ, Beudeker BJ, Kreefft K,
et al
PLoS One.
2016 Jul 14;11(7):e0159243
Paper
Update on Current Evidence for Hepatitis C Therapeutic Options in HCV
Mono-infected Patients.
Hull MW, Yoshida EM, Montaner JS.
Curr Infect Dis Rep.
2016 Jul;18(7):22.
Abstract
Impact of HCV genotype on treatment regimens and drug resistance: a snapshot in
time.
Cuypers L, Ceccherini-Silberstein F,
et al
Rev Med Virol.
2016 Jul 12.
Abstract
Emerging biological agents for hepatitis C.
Zuccaro V, Columpsi P, Apollinari A,
et al
Expert Opin
Emerg Drugs. 2016
Jun;21(2):219-24.
Abstract
Australian recommendations for the management of hepatitis C virus infection: a
consensus statement.
Thompson AJ.
Med J Aust. 2016 Apr
18;204(7):268-72.
Abstract
Effects of Viral Eradication in Patients with HCV and Cirrhosis Differ With
Stage of Portal Hypertension.
Di Marco V, Calvaruso V, Ferraro D, et al
Gastroenterology. 2016 Mar 31
Abstract
Recent advances in managing chronic HCV infection: focus on therapy in patients
with severe liver disease.
Maan R, van der Meer AJ.
et al
F1000Res.
2016 Mar 17;5. pii: F1000 Faculty Rev-367
Abstract
FULL-TEXT ARTICLE
Hepatitis C virus:
A time for decisions. Who should be treated and when?
Attar BM, Van Thiel DH.
World J Gastrointest Pharmacol Ther.
2016 Feb 6;7(1):33-40
Paper
Successful achievement of sustained virological response to triple combination
therapy containing simeprevir in two patients with chronic hepatitis C who had
failed asunaprevir-daclatasvir combination therapy.
Ozeki I, Nakajima T, Yamaguchi M, Kimura M,
et al
Hepatol Res. 2016 Feb 9.
Abstract
Therapeutic Advances in HCV Genotype 1 Infection: Insights from
the Society of Infectious Diseases Pharmacists.
Deming P, Martin MT, Chan J, Dilworth TJ, et A;
Pharmacotherapy. 2016 Feb 5.
Abstract
FULL-TEXT ARTICLE
New approaches
in the treatment of hepatitis C.
Gonz�lez-Grande R, Jim�nez-P�rez M, Gonz�lez Arjona C, Mostazo Torres
J.World
J Gastroenterol. 2016 Jan
28;22(4):1421-32
Paper
The current treatment of Hepatitis C.
Arleo A, Mangia A.
Minerva Gastroenterol Dietol. 2016 Jan 22.
Abstract
Follow-up of patients with chronic hepatitis C and a
sustained viral response.
Serfaty L.
Liver Int. 2016 Jan;36 Suppl 1:67-71
Abstract
Why do I treat my patients with mild hepatitis C?
Calvaruso V, Crax� A.
Liver Int. 2016
Jan;36 Suppl 1:7-12..
Abstract
The role of HCV proteins on
treatment outcomes.
Kumthip K, Maneekarn N.
Virol J.
2015 Dec 15;12(1):217
Abstract
Hepatitis C Virus: Current and Evolving Treatments for
Genotype 4.
Asselah T,
Bourli�re M.
Gastroenterol Clin North Am. 2015
Dec;44(4):859-70
Abstract
Hepatitis C Virus: Current and Evolving Treatments for Genotypes 2 and 3.
Ampuero J, Romero-G�mez M.
Gastroenterol Clin North Am.
2015 Dec;44(4):845-57.
Abstract
Variation in Treatment Priorities for Chronic Hepatitis C: A
Latent Class Analysis.
Fraenkel L, Lim J,
Garcia-Tsao G, et al
Patient.
2015 Oct 30.
Abstract
Hepatitis C virus treatment in the real world: optimising
treatment and access to therapies.
Zoulim F, Liang TJ,
Gerbes AL, et al
Gut. 2015
Nov;64(11):1824-33.
Abstract
Regimens for the Hepatitis C Treatment-Naive Patient.
Ayoub WS, Tran TT.
Clin Liver Dis.
2015 Nov;19(4):619-27.
Abstract
HCV Council – Critical Appraisal of Data: Recommendations for
Clinical Practice in a Rapidly Evolving Therapeutic Landscape.
Reau N, Fried MW,
Nelson DR,
et al
Liver Int. 2015 Oct 28.
Abstract
All-oral interferon-free treatments: The end of hepatitis C virus story, the
dream and the reality.
Adinolfi LE, Guerrera B.
World J Hepatol.
2015 Oct 8;7(22):2363-8.
Abstract
Treatment of HCV in Patients who Failed First-Generation PI
Therapy: a Review of Current Literature.
Kwo PY, Badshah MB.
Curr Gastroenterol Rep.
2015 Oct;17(10):462.
Abstract
Current guidelines and prioritizing treatment of hepatitis C virus in
HIV-infected patients.
Feeney ER, Chung RT, Yazdanpanah Y.
Curr Opin HIV AIDS. 2015 Sep;10(5):323-9.
Abstract
Hepatitis C: Treatment of difficult to treat patients.
Hilgenfeldt EG, Schlachterman A, Firpi RJ.
World J Hepatol.
2015 Jul 28;7(15):1953-63.
Abstract
Novel Hepatitis C Treatment and the Impact on Kidney Transplantation.
Sawinski D, Bloom RD.
Transplantation.
2015 Jul 25.
Abstract
Optimizing patient treatment decisions in an era of rapid
technological advances: the case of hepatitis C treatment.
Liu S, Brandeau ML,
Goldhaber-Fiebert JD.
Health Care Manag Sci.
2015 Jul 19.
Abstract
FULL-TEXT ARTICLE
Treatment guidelines for Hepatitis C in Spain.
Crespo-Casal M.
Rev Esp Sanid Penit.
2015 Oct;17(2):37-47
Paper
FULL-TEXT ARTICLE
Rational Design and Adaptive Management of Combination Therapies for
Hepatitis C Virus Infection.
Ke R, Loverdo C, Qi H, et
al
PLoS Comput Biol. 2015
Jun 30;11(6):e1004040
Paper
The patient’s journey with chronic hepatitis C from
interferon plus ribavirin to interferon- and ribavirin-free regimens: a
study of health-related quality of life.
Younossi ZM, Stepanova M,
Nader F, et al
Aliment Pharmacol Ther.
2015 Jun 9.
Abstract
Long-term treatment outcomes of patients infected with
Hepatitis C virus: a systematic review and meta-analysis of the survival
benefit of achieving a Sustained Virological Response.
Simmons B, Saleem J, Heath K, C et al
Clin Infect Dis. 2015 May
17. .
Abstract
Hepatitis C Management and the Infectious Diseases Physician:
A Survey of Current and Anticipated Practice Patterns.
Chastain CA, Beekmann SE,
Wallender EK, et al
Clin Infect Dis.
2015 May 15.
Abstract
Simultaneously Targeting the NS3 Protease And Helicase
Activities For More Effective Hepatitis C Virus Therapy.
Ndjomou J, Corby MJ, Sweeney NL,
et al
ACS Chem Biol. 2015 May 11
Abstract
Treatment of hepatitis C in difficult-to-treat patients.
Ferenci P.
Nat Rev Gastroenterol Hepatol. 2015
Apr 21.
Abstract
Effect of addition of statins to antiviral therapy in HCV
infected persons: Results from ERCHIVES.
Butt AA, Yan P,
Bonilla H, et al
Hepatology. 2015
Apr 6.
Abstract
FULL-TEXT ARTICLE
Chronic
hepatitis C genotype 1 treatment roadmap for resource constrained settings.
Lim SG.
World J Gastroenterol.
2015 Feb 14;21(6):1972-81.
Paper
Long-term follow-up of successful hepatitis C virus therapy:
waning immune responses and disappearance of liver disease are consistent
with cure.
Hedenstierna M,
Weiland O, Brass A,
et al
Aliment Pharmacol Ther. 2015 Jan 28.
Abstract
Strategies to manage hepatitis C virus (HCV) infection
disease burden – volume 2.
Gane E,
Kershenobich D, Seguin-Devaux C ,et
al
J
Viral Hepat. 2015 Jan;22 Suppl
1:46-73
Abstract
Treatment of Hepatitis C in Liver Transplant Patients:
Interferon OUT, Direct Antiviral Combos IN.
Price JC, Terrault
NA.
Liver Transpl. 2015
Jan 20.
Abstract
Long-term effect of HCV eradication in patients with mixed
cryoglobulinemia: A prospective, controlled, open-label, cohort study.
Gragnani L, Fognani E, Piluso A,
et al
Hepatology. 2014 Nov
27.
Abstract
New kids on the block-step by step to an ideal HCV therapy.
Cornberg M, Manns MP.
Lancet. 2014 Nov 11. pii: S0140-6736(14)62008-0.
Abstract
Strategies for the treatment of Hepatitis C in an era of
interferon-free therapies: what public health outcomes do we value most?
Innes H, Goldberg D, Dillon
J, Hutchinson SJ.
Gut. 2014 Nov 6.
Abstract
FULL-TEXT ARTICLE
Recent advances in the treatment of hepatitis C.
Dhingra A, Kapoor S, Alqahtani SA.
Discov Med.
2014 Oct;18(99):203-8.
Paper
The Impact of IFNL4 rs12979860 Polymorphism on
Spontaneous Clearance of Hepatitis C; A Case-Control Study.
Sharafi H, Alavian SM, Behnava B,
et al
Hepat Mon. 2014 Oct
1;14(10):e22649.
Abstract
Screening, Diagnosis, Treatment, and Management of Hepatitis C: A Novel,
Comprehensive, Online Resource Center for Primary Care Providers and
Specialists.
Lebovics E, Czobor K.
Am J Med. 2014 Oct 9. pii:
S0002-9343(14)00888-2.
Abstract
New hepatitis C treatments: pharmacological considerations
and potential for drug interactions.
Chtioui H, Buclin T,
Moradpour D.
Rev Med
Suisse. 2014 Sep 3;10(440):1600-4,.
Abstract
FULL-TEXT ARTICLE
Challenging clinical
cases in HCV infection.
Strazzulla A, Matera G, Mammone S, et al
BMC Infect Dis. 2014 Sep 5;14
Suppl 5:S7.
Paper
Benefits of Hepatitis C Virus treatment: a balance of preventing onwards
transmission and re-infection.
de Vos AS, Kretzschmar ME.
Math Biosci. 2014 Sep
18.
Abstract
FULL-TEXT PDF ARTICLE
Fighting an uphill battle": experience with the HCV triple therapy: a
qualitative thematic analysis.
Rasi M, K�nzler-Heule P, Schmid P, et al
BMC Infect Dis.
2014 Sep 18;14(1):507.
.
Paper
Hepatitis C virus genotype 3: a genotype that is not ‘easy-to-treat’
Buti M, Esteban R.
Expert Rev Gastroenterol Hepatol. 2014 Sep 15:1-11.
Abstract
Autophagy in HCV Infection: Keeping Fat and Inflammation at
Bay.
Vescovo T, Refolo G, Romagnoli A, et al
Biomed Res Int. 2014;2014:265353.
Abstract
Early viral kinetics during hepatitis C virus genotype 6
treatment according to IL28B polymorphisms.
Akkarathamrongsin S, Payungporn S, Thong VD,
et al
World J Gastroenterol.
2014 Aug 14
Abstract
Late diagnosis of hepatitis C virus infection in the Chronic
Hepatitis Cohort Study (CHeCS): Missed opportunities for intervention.
Moorman AC, Xing J, Ko S, et al
Hepatology.
2014 Aug 13
Abstract
Treatment of hepatitis C: a systematic review.
Kohli A, Shaffer A,
Sherman A, Kottilil S.
JAMA. 2014 Aug 13;312(6):631-40
Abstract
New Therapies for Hepatitis C: Considerations in Patients
with Renal Impairment.
Zimner-Rapuch S,
Janus N, Deray G, Launay-Vacher V.
Drugs. 2014 Jul 25
Abstract
Health policy model: long-term predictive results associated with the
management of hepatitis C virus-induced diseases in Italy.
Mennini FS, Marcellusi A, Andreoni M, et al
Clinicoecon Outcomes Res.
2014 Jun 19;6:303-10
Abstract
Medicinal plants used in malaria treatment by Prometra
herbalists in Uganda.
Adia MM, Anywar G, Byamukama R,
et al
J Ethnopharmacol. 2014 Jun 11.
Abstract
Restoration of HCV-specific CD8+ T-cell function by Interferon-free therapy.
Martin B, Hennecke N, Lohmann V, et al
J Hepatol.
2014 Jun 3.
Abstract
FULL-TEXT ARTICLE
The hepatitis C cascade of care: identifying priorities to improve clinical
outcomes.
Linas BP, Barter DM, Leff JA, et al
PLoS One. 2014 May 19;9(5):e97317.
Paper
FULL-TEXT
ARTICLE
Therapy of Hepatitis
C – Back to the Future.
Liang TJ, Ghany MG.
N Engl J Med. 2014 May 4
Paper
The Rapid Evolution of Treatment Strategies for Hepatitis C.
Muir AJ.
Am J Gastroenterol. 2014 Apr 15.
Abstract
Reversal, maintenance or progression: What happens to the liver after a
virologic cure of hepatitis C?
Lee YA, Friedman SL.
Antiviral Res. 2014 Apr 9.
Abstract
Strategies to manage hepatitis C virus (HCV) disease
burden.
Wedemeyer H, Duberg AS, Buti M, et al
J Viral Hepat. 2014 May;21 Suppl
1:60-89.
Abstract
Curing Chronic Hepatitis C – The Arc of a Medical Triumph.
Chung RT, Baumert TF.
N Engl J Med. 2014
Apr 10
Abstract
FULL-TEXT ARTICLE
Challenges in
managing hepatitis C virus infection in cancer patients.
Borchardt RA, Torres HA.
World J Gastroenterol.
2014 Mar 21;20(11):2771-2776
Paper
What are the pros and cons of the use of host-targeted agents
against hepatitis C?
Pawlotsky JM.
Antiviral
Res.
2014 Feb 25.
Abstract
Treatment of hepatitis C virus genotype 3-infection.
Pol S, Vallet-Pichard A, Corouge M.
Liver Int. 2014 Feb;34
Suppl 1:18-23
Abstract
How to optimize current treatment of genotype 2 hepatitis C virus infection.
Marciano S, Gadano AC.
Liver Int. 2014 Feb;34 Suppl 1:13-7.
Abstract
Treatment of Chronic Hepatitis C Virus Infection: Some Remaining Obstacles in
the United States.
Searson G, Engelson ES, Carriero D, Kotler DP.
Liver
Int. 2014 Jan 13.
Abstract
Predictors of hepatitis C treatment response: what’s new?
Berry L, Irving W.
Expert Rev Anti Infect Ther.
2014 Jan 3.
Abstract
FULL-TEXT ARTICLE
Prospects for nucleic acid-based therapeutics against hepatitis C virus.
Lee
CH, Kim JH, Lee SW.
World J Gastroenterol. 2013 Dec 21;19(47):8949-8962
Paper
Predictors of the therapeutic response in hepatitis C. A 2013 update.
Arnaud C, Tr�po C, Petit MA.
Clin Res Hepatol Gastroenterol.
2013 Nov 20.
Abstract
Treatment as prevention and cure towards global
eradication of hepatitis C virus.
Hagan LM, Wolpe PR, Schinazi RF.
Trends Microbiol. 2013 Nov 13.
Abstract
After the Cure: Management of HCV After Achievement of
SVR.
Zator ZA, Chung RT.
Curr
HIV/AIDS Rep.
2013 Nov 12.
Abstract
FULL-TEXT ARTICLE
Hepatitis C,
stigma and cure.
Marinho RT, Barreira DP.
World J Gastroenterol.
2013
Oct 28;19(40):6703-
Paper
FULL-TEXT ARTICLE
Hepatitis C genotype 6: A concise review and response-guided
therapy proposal.
Bunchorntavakul C, Chavalitdhamrong D, Tanwandee T.
World J Hepatol. 2013 Sep
27;5(9):496-504.
.
Paper
Impact of Hepatitis C Treatment Initiation on Adherence
to Concomitant Medications.
Pizzirusso M, Lin J,
Head C, et al
J Assoc Nurses AIDS Care. 2013
Sep 24..
Abstract
Viral Breakthrough Is Associated With Resistance Using
Direct Acting Agents in Patients Treated for Chronic Hepatitis C
Infection.
Zhou K, Ferguson J, Bau S,
Saab S.
J Clin Gastroenterol.
2013 Sep 16
Abstract
Treatment decisions and contemporary versus pending treatments
for hepatitis C.
Trembling PM, Tanwar S, Rosenberg
WM, Dusheiko GM.
Nat Rev Gastroenterol Hepatol. 2013 Sep
10.
Abstract
Current and future therapies for hepatitis C virus infection:
from viral proteins to host targets.
Imran
M, Manzoor S, Khattak NM
Arch Virol. 2013 Aug 25.
Abstract
Pretreatment predictive factors for hepatitis C therapy outcome: relevance of
anti-E1E2 antibodies compared to IP-10 and IL28B genotypes.
Arnaud C, Pradat P, Spaziante M, et al
Antivir Ther.
2013 Aug 15.
Abstract
Containing "The Great Houdini" of viruses: Combining direct acting antivirals
with the host immune response for the treatment of chronic hepatitis C.
Ahl�n G, Frelin L, Brennd�rfer ED, et al
Drug Resist Updat.
2013 Aug 1.
Abstract
Hepatitis C Virus: Standard-of-Care Treatment.
Pawlotsky JM.
Adv Pharmacol. 2013;67:169-215.
Abstract |
